New Market Study, "Philippines Pharmaceuticals & Healthcare Report Q4 2013", Has Been Published
BMI View: Rising healthcare expenditure will be one of the key drivers of pharmaceutical growth in the Philippines as the country's intention to provide universal healthcare coverage sets the stage for increased access to health and pharmaceutical services. In addition to improving access to healthcare, the country is also looking to boost efforts in research and medical tourism. If successful, this will boost Philippines's pharmaceutical business environment. A downside risk to our view is that the majority of the South...
View full press release